[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100547607":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":33,"responsibleParty":52,"collaborators":55,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":10,"maxAge":10,"enrollmentInfo":68,"targetDuration":10,"studyType":71,"phases":10,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":79,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Ottawa Fertility Centre","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Cohort Group",null,"Evaluating the anticipated utility of the Mira device for detection of the LH surge, in natural cycle frozen embryo transfer protocols",[13],"Device: MIRA Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","MIRA Device","At home diagnostic testing",[9],[21],"Device wands",[23],{"name":24,"affiliation":5,"role":25},"Jenna Gale, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Jennifer McDowall","CONTACT","613-686-3378","620","jmcdowall@conceive.ca",[34],{"facility":35,"status":10,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Olive Fertility Centre","Vancouver","British Columbia","V5Z 3X7","Canada","CA",{"type":42,"coordinates":43},"Point",[44,45],-123.11934,49.24966,{"lat":45,"lon":44},[48,51],{"name":49,"role":29,"phone":50,"phoneExt":10,"email":10},"Gary Nakhuda, MD","604-559-9950",{"name":49,"role":25,"phone":10,"phoneExt":10,"email":10},{"type":25,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Dr. Jenna Gale","Research Director",[56],{"name":57,"class":58},"Quanovate Tech Inc.","INDUSTRY","100547607","correlation-of-urinary-and-serum-hormone-levels-in-natural-cycle-frozen-embryo-transfer-cycles-100547607",false,"NCT06410170","Correlation of Urinary and Serum Hormone Levels in Natural Cycle Frozen Embryo Transfer Cycles","MIRA","Inclusion Criteria:\n\n* All patients scheduled for a natural cycle frozen embryo transfer\n* Agree to participate in the research study\n\nExclusion Criteria:\n\n* There are no exclusions",true,"FEMALE",{"count":69,"type":70},100,"ESTIMATED","OBSERVATIONAL","To evaluate whether the measurement of urinary estrone glucuronide and luteinizing hormone (LH) concentrations with an at-home device is correlated with serum hormone levels within a natural cycle frozen embryo transfer protocol.\n\nThe hypothesis is that home urinary monitoring can reliably detect the LH surge and serve as a trigger for timing the FET. Results of this study may ultimately lead to change in clinical practice by reducing the number of clinic visits for serum monitoring, offering a more convenient, time and cost saving method of detection of LH surge. If the proposed protocol were feasible and widely accepted by patients, this would prompt the wide adoption of a less invasive but equally as effective FET protocol.",[74],"Fertility Issues",[76,77,78],"Mira device","Fertility tracking","At home use","NOT_YET_RECRUITING","2024-06-06",{"date":82,"type":83},"2024-06-10","ACTUAL",{"date":85,"type":70},"2024-06",{"date":87,"type":70},"2025-12",{"name":5,"class":6},1]